Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

CryoCath Freezor CryoAblation Catheter System (CRYOFACTS)

Study:

CryoCath Freezor CryoAblation Catheter System (CRYOFACTS)

Rationale:

n/a

Purpose:

The purpose of this post approval study of heart block is to gather additional information regarding how often patients develop heart block (atrioventricular block) after having standard ablation procedure using cryotherapy with the Freezorâ„¢ catheter.

Study Status: Recruiting

Recruiting:
Michelle Baksar 216-445-4437 baksarm@ccf.org

Condition Intervention Phase
Tachycardia, Atrioventricular Nodal Reentry Device: Freezor® Cardiac Cryoablation Catheter CryoConsole System Phase 4

Verified by Medtronic Atrial Fibrillation Solutions August, 2013

Sponsored by: Medtronic Atrial Fibrillation Solutions
Information provided by: Medtronic Atrial Fibrillation Solutions
ClinicalTrials.gov identifier: NCT00621621

Study Type: Interventional

Study Design: Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

John Lehmann, MD, MPH., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site